Quality Certification Milestones
November Artesunate tablets passed the WHO quality audit (re-examination).
April All product production lines of the company have passed China GMP certification.
December Artesunate tablets passed the WHO quality audit.
Artesunate was recognized as an essential drug by the WHO and included in the 'WHO Essential Drug List'.
Domestic exclusive product, Bumetanide Tablets, passed the US FDA certification.
Guilin Pharma successfully invented artesunate and obtained China x-01 first-class new drug certificate.